Search PubMed⌕ Search

Biomedical subjects

Julie Carter

Publications and source records attributed to Julie Carter.

5 recordsLinked to original sources

Fingerprinting suspended sediment sources in a large urban river system.

Very few studies have attempted to quantify the sources of suspended sediment transported in urban river systems. In this study, statistically verified composite fingerprints and a multivariate mixing model have been used to identify the main sources of the suspended sediment transported by the River Aire and its main tributary, the River Calder. Because of the polluted nature of the Aire/Calder catchment and its effect on fingerprint property concentrations, source tracing was undertaken separately for the upper and lower reaches. The mean contributions from individual source types (i.e. surface materials from woodland, uncultivated and cultivated areas, channel bank material, road dust and solids from sewage treatment works) varied between the upper and lower reaches of the rivers, reflecting the change in land use from primarily pasture and moorland in the upper reaches to mainly urban areas (with some cultivated land) in the lower reaches. The suspended sediment in the upper reaches of the River Aire originates largely from channel bank sources (43-84%) and from uncultivated topsoil (16-57%). In the lower reaches of the Aire/Calder system, local sources of cultivated topsoil contribute 20-45% of the suspended sediment load and there is a significant contribution from urban sources, such as road dust (19-22%) and solids from sewage treatment works (14-18%). In the upper reaches, the proportion of sediment derived from each of the two main geological areas corresponds broadly to the proportion of the catchment occupied by each geological area. The relative contribution from the Rivers Aire and Calder to the suspended sediment load transported below the confluence demonstrates that most of the sediment is derived from the River Calder.

Journal Article↗

Puberty advice for year 6 and 7 boys and girls.

Two nurses who are clinical leaders in school health explain why education about puberty and adolescence is so much needed by 10 and 11-year-old pupils in Years 6 and 7. The transition from primary to secondary school coincides with the transition from childhood to puberty and adolescence. With such major physical, emotional and psychological development at this stage in their lives, boys and girls need support and information which the school nurse is well placed to provide. Based on extensive experience of giving talks and working with pupils of this age group, the authors provide some practical tips for school nurses and others giving sex and relationship education to Years 6 and 7.

Child↗

This could catch on.

Explore the source record for details and available documents.

Attitude of Health Personnel↗

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

BACKGROUND: Parkinson disease (PD) is a degenerative neurological disorder for which no treatment has been shown to slow the progression. OBJECTIVE: To determine whether a range of dosages of coenzyme Q10 is safe and well tolerated and could slow the functional decline in PD. DESIGN: Multicenter, randomized, parallel-group, placebo-controlled, double-blind, dosage-ranging trial. SETTING: Academic movement disorders clinics. PATIENTS: Eighty subjects with early PD who did not require treatment for their disability. INTERVENTIONS: Random assignment to placebo or coenzyme Q10 at dosages of 300, 600, or 1200 mg/d. MAIN OUTCOME MEASURE: The subjects underwent evaluation with the Unified Parkinson Disease Rating Scale (UPDRS) at the screening, baseline, and 1-, 4-, 8-, 12-, and 16-month visits. They were followed up for 16 months or until disability requiring treatment with levodopa had developed. The primary response variable was the change in the total score on the UPDRS from baseline to the last visit. RESULTS: The adjusted mean total UPDRS changes were +11.99 for the placebo group, +8.81 for the 300-mg/d group, +10.82 for the 600-mg/d group, and +6.69 for the 1200-mg/d group. The P value for the primary analysis, a test for a linear trend between the dosage and the mean change in the total UPDRS score, was.09, which met our prespecified criteria for a positive trend for the trial. A prespecified, secondary analysis was the comparison of each treatment group with the placebo group, and the difference between the 1200-mg/d and placebo groups was significant (P =.04). CONCLUSIONS: Coenzyme Q10 was safe and well tolerated at dosages of up to 1200 mg/d. Less disability developed in subjects assigned to coenzyme Q10 than in those assigned to placebo, and the benefit was greatest in subjects receiving the highest dosage. Coenzyme Q10 appears to slow the progressive deterioration of function in PD, but these results need to be confirmed in a larger study.

Administration, Oral↗

Eating for health.

Explore the source record for details and available documents.

Diet↗